AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION: Form 990, tax year 2010
View the entire original 990 at ProPublica ↗
- Organization
- AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS RESEARCH AND EDUCATION (EIN 23-7033369)
- Tax period
- 2010-06-01 to 2011-05-31
- Filed
- 2012-04-02
- IRS object ID
- 201230939349300508
- Schema version
- 2010v3.4
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule D
- Schedule G
- Schedule I
- Schedule J
- Schedule M
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Timestamp | 2012-04-02T09:46:37-05:00 | Timestamp |
| Tax Period End Date | 2011-05-31 | TaxPeriodEndDate |
Preparer Firm PreparerFirm
Preparer Firm Business Name PreparerFirmBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | TATE AND TRYON | BusinessNameLine1 |
Preparer Firm US Address PreparerFirmUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2021 L STREET NW SUITE 400 | AddressLine1 |
| City | WASHINGTON | City |
| State | DC | State |
| ZIP Code | 20036 | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnType |
| Tax Period Begin Date | 2010-06-01 | TaxPeriodBeginDate |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 237033369 | EIN |
Name Name
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | AMERICAN SOCIETY OF HEALTH-SYSTEM | BusinessNameLine1 |
| Business Name Line2 | PHARMACISTS RESEARCH AND EDUCATION FDTN | BusinessNameLine2 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name Control | AMER | NameControl |
| Phone | 3016648612 | Phone |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 7272 WISCONSIN AVENUE 2ND FLOOR | AddressLine1 |
| City | BETHESDA | City |
| State | MD | State |
| ZIP Code | 20814 | ZIPCode |
Officer Officer
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name | STEPHEN J ALLEN | Name |
| Title | EXECUTIVE VICE PRESIDENT AND CEO | Title |
| Phone | 3016648612 | Phone |
| Date Signed | 2012-04-02 | DateSigned |
| Authorize Third Party | 1 | AuthorizeThirdParty |
Preparer Preparer
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name | DEBORAH G KOSNETT | Name |
| Phone | 2022932200 | Phone |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax Year | 2010 | TaxYear |
| Build TS | 2016-02-24 21:20:13Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name Of Principal Officer Person | STEPHEN J ALLEN | NameOfPrincipalOfficerPerson |
Address Principal Officer US AddressPrincipalOfficerUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 7272 WISCONSIN AVENUE 2ND FLOOR | AddressLine1 |
| City | BETHESDA | City |
| State | MD | State |
| ZIP Code | 20814 | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | 4297100 | GrossReceipts |
| Group Return For Affiliates | 0 | GroupReturnForAffiliates |
| Organization501c3 | X | Organization501c3 |
| Web Site | WWW.ASHPFOUNDATION.ORG | WebSite |
| Type Of Organization Corporation | X | TypeOfOrganizationCorporation |
| Year Formation | 1968 | YearFormation |
| State Legal Domicile | MD | StateLegalDomicile |
| Activity Or Mission Description | FOSTERING SAFE AND EFFECITVE MEDICATION USE. TO PROMOTE THE PUBLIC INTEREST THROUGH DEVELOPMENT OF HIGH QUALITY PHARMACEUTICAL SERVICES IN HEALTH SYSTEMS. TO ENCOURAGE, PROVIDE FOR AND ENGAGE IN SCIENTIFIC RESEARCH, PROFESSIONAL STUDY AND ADVANCEMENT OF THE SCIENCE OF PHARMACY IN HEALTH SYSTEMS. TO IMPROVE THE QUALITY AND INCREASE THE AVAILABILITY OF PHARMACEUTICAL SERVICES TO THE PUBLIC. | ActivityOrMissionDescription |
| Nbr Voting Members Governing Body | 10 | NbrVotingMembersGoverningBody |
| Nbr Independent Voting Members | 8 | NbrIndependentVotingMembers |
| Total Nbr Employees | 0 | TotalNbrEmployees |
| Total Nbr Volunteers | 100 | TotalNbrVolunteers |
| Total Gross UBI | 0 | TotalGrossUBI |
| Net Unrelated Business Txbl Income | 0 | NetUnrelatedBusinessTxblIncome |
| Contributions Grants Prior Year | 1993575 | ContributionsGrantsPriorYear |
| Contributions Grants Current Year | 2697502 | ContributionsGrantsCurrentYear |
| Program Service Revenue Prior Year | 155612 | ProgramServiceRevenuePriorYear |
| Program Service Revenue CY | 216540 | ProgramServiceRevenueCY |
| Investment Income Prior Year | 1220437 | InvestmentIncomePriorYear |
| Investment Income Current Year | 1315173 | InvestmentIncomeCurrentYear |
| Other Revenue Prior Year | -9853 | OtherRevenuePriorYear |
| Other Revenue Current Year | -7191 | OtherRevenueCurrentYear |
| Total Revenue Prior Year | 3359771 | TotalRevenuePriorYear |
| Total Revenue Current Year | 4222024 | TotalRevenueCurrentYear |
| Grants And Similar Amnts Prior Year | 497824 | GrantsAndSimilarAmntsPriorYear |
| Grants And Similar Amnts CY | 349477 | GrantsAndSimilarAmntsCY |
| Benefits Paid To Members Prior Year | 0 | BenefitsPaidToMembersPriorYear |
| Benefits Paid To Members CY | 0 | BenefitsPaidToMembersCY |
| Salaries Etc Prior Year | 1057637 | SalariesEtcPriorYear |
| Salaries Etc Current Year | 1178599 | SalariesEtcCurrentYear |
| Total Prof Fundrsng Exp Prior Year | 0 | TotalProfFundrsngExpPriorYear |
| Total Prof Fundrsng Exp CY | 0 | TotalProfFundrsngExpCY |
| Total Fundrsng Exp Current Year | 405962 | TotalFundrsngExpCurrentYear |
| Other Expense Prior Year | 748340 | OtherExpensePriorYear |
| Other Expenses Current Year | 1161985 | OtherExpensesCurrentYear |
| Total Expenses Prior Year | 2303801 | TotalExpensesPriorYear |
| Total Expenses Current Year | 2690061 | TotalExpensesCurrentYear |
| Revenues Less Expenses Prior Year | 1055970 | RevenuesLessExpensesPriorYear |
| Revenues Less Expenses CY | 1531963 | RevenuesLessExpensesCY |
| Total Assets BOY | 9832251 | TotalAssetsBOY |
| Total Assets EOY | 11482201 | TotalAssetsEOY |
| Total Liabilities BOY | 271704 | TotalLiabilitiesBOY |
| Total Liabilities EOY | 389691 | TotalLiabilitiesEOY |
| Net Assets Or Fund Balances BOY | 9560547 | NetAssetsOrFundBalancesBOY |
| Net Assets Or Fund Balances EOY | 11092510 | NetAssetsOrFundBalancesEOY |
| Info In Schedule O Part III | X | InfoInScheduleOPartIII |
| Mission Description | THE MISSION OF THE ASHP FOUNDATION IS TO IMPROVE THE HEALTH AND WELL-BEING OF PATIENTS IN HOSPITALS AND HEALTH SYSTEMS THROUGH APPROPRIATE, SAFE AND EFFECTIVE MEDICATION USE. THE FOUNDATION PROVIDES LEADERSHIP AND CONDUCTS EDUCATION AND RESEARCH ACTIVITIES THAT FOSTER THE COORDINATION OF INTERDISCIPLINARY MEDICATION MANAGEMENT LEADING TO OPTIMAL PATIENT OUTCOMES. EMPHASIS IS GIVEN TO PROGRAMS THAT WILL HAVE A MAJOR IMPACT ON ADVANCING PHARMACY PRACTICE IN HOSPITALS AND HEALTH SYSTEMS, THEREBY IMPROVING PUBLIC HEALTH. | MissionDescription |
| Significant New Program Services | 0 | SignificantNewProgramServices |
| Significant Change | 0 | SignificantChange |
| Expense | 1102167 | Expense |
| Grants | 87172 | Grants |
| Revenue | 216540 | Revenue |
| Description | EXPANSION OF PHARMACISTS' DIRECT PATIENT CARE AND LEADERSHIP ROLES ASHP FOUNDATION RESEARCH ADVISORY PANEL-THE RESEARCH ADVISORY PANEL (RAP), CHAIRED BY DR. MICHAEL MILLER OF THE UNIVERSITY OF OKLAHOMA, MET IN PERSON AT THE ASHP MIDYEAR CLINICAL MEETING IN DECEMBER 2010 AND BY TELECONFERENCE THROUGHOUT THE YEAR. THE ASHP FOUNDATION VICE PRESIDENT WORKED CLOSELY WITH THE PANEL TO ESTABLISH RESEARCH PRIORITIES FOR THE PHARMACY PRACTICE MODEL INITIATIVE AND THE ASHP FOUNDATION'S NEW INVESTIGATOR RESEARCH GRANT PROGRAMS. IN ADDITION, THE RAP PROVIDED GUIDANCE ON REVISIONS TO THE LITERATURE AWARDS PROGRAM. CENTER FOR HEALTH-SYSTEM PHARMACY LEADERSHIP-THE CENTER WAS DEVELOPED AS A COLLABORATIVE PROGRAMMATIC OFFERING OF ASHP AND THE ASHP FOUNDATION, AND IS ADMINISTERED BY THE FOUNDATION. THE CENTER HAS BEEN IN OPERATION SINCE JANUARY 2007. ITS PRIMARY OBJECTIVES ARE TO: (1) ASSURE THAT PHARMACY LEADERS HAVE THE KNOWLEDGE NECESSARY TO PROACTIVELY INFLUENCE THE ADVANCEMENT OF THE MEDICATION-USE PROCESS BY PROVIDING COMPETENCY-BASED EDUCATION OPPORTUNITIES, (2) PROVIDE LEADERSHIP DEVELOPMENT PROGRAMS FOR STUDENTS, RESIDENTS AND NEW PRACTITIONERS THAT PROMOTE THE IMPORTANT ROLE OF THE PHARMACIST AS A CHANGE AGENT AND A LEADER IN PATIENT CARE, (3) INTEGRATE INTO HEALTH-SYSTEM LEADERSHIP DECISION-MAKING THE CRITICAL ROLE FOR PHARMACISTS AS ACTIVE PARTICIPANTS IN ACHIEVING ORGANIZATIONAL OBJECTIVES, (4) CONDUCT RESEARCH ON EFFECTIVE PHARMACY MANAGEMENT AND LEADERSHIP IN ACHIEVING THE OBJECTIVES OF HOSPITALS AND HEALTH SYSTEMS, AS WELL AS IMPROVING COMMUNITY DISEASE PREVENTION AND HEALTH PROMOTION EFFORTS AND (5) EXPLORE THE PURPOSE AND VALUE OF A CREDENTIAL FOR HOSPITAL AND HEALTH-SYSTEM PHARMACY LEADERS THAT RECOGNIZES COMPETENCIES TO DIRECT THE MEDICATION-USE SYSTEMS ENTERPRISE AND PROMOTE SAFETY AND COST-EFFECTIVE MEDICATION OUTCOMES. IN FY11 THE CENTER WAS ABLE TO COMPLETE OBJECTIVE #5 BY DETERMINING THAT AN ADDITIONAL CREDENTIAL IS NOT NEEDED FOR HEALTH-SYSTEM PHARMACY DIRECTORS/CHIEF PHARMACY OFFICERS. THE CENTER IS NOW EXPANDING OPPORTUNITIES FOR THESE LEADERS TO PURSUE MASTER'S DEGREES IN BUSINESS, HEALTH CARE ADMINISTRATION, INFORMATION MANAGEMENT AND PUBLIC HEALTH.THE CENTER ADVISORY PANEL (CAP)-THIS ADVISORY PANEL WAS ESTABLISHED IN FY08 AND IS A 12-MEMBER GROUP THAT HAS SERVED AS AN EXTERNAL RESOURCE OF EXPERTS PROVIDING AN ENVIRONMENTAL SCAN OF PRACTICE ISSUES AND SIGNIFICANT EVENTS THAT MIGHT AFFECT THE CENTER'S PLAN OF ACTION. THE CAP MET ONCE IN FY11 AND DETERMINED THAT ITS VALUE WAS OPTIMAL DURING THE INITIAL YEARS OF THE CENTER FOR HEALTH-SYSTEM PHARMACY LEADERSHIP. THE CAP OFFICIALLY DISBANDED AT THE END OF FY11, AND PROGRAMMATIC INPUT FOR THE CENTER WILL BE PROVIDED BY THE ASHP SECTION LEADERSHIP, COUNCILS AND COMMISSIONS.PHARMACY LEADERSHIP ACADEMY (PLA)-THE PLA IS SUPPORTED IN PART BY AN EDUCATIONAL GRANT FROM AMGEN. THE PLA IS DESIGNED TO PROVIDE ADDITIONAL COMPREHENSIVE TRAINING TO PHARMACY LEADERS BEYOND WHAT IS LEARNED IN PHARMACY RESIDENCIES, SHORT COURSES AND OTHER EDUCATIONAL PROGRAMS. THE ACADEMY PROVIDES LEADERSHIP TRAINING APPLICABLE TO CLINICAL AND ADMINISTRATIVE PHARMACY PRACTITIONERS IN SMALL TO LARGE HOSPITALS AND HEALTH SYSTEMS WHO ASPIRE TO LEADERSHIP POSITIONS IN HEALTH-SYSTEM PHARMACY. MOST IMPORTANTLY, THIS PROGRAM DIRECTLY BENEFITS PATIENTS BECAUSE PARTICIPANTS APPLY THEIR NEW-FOUND SKILLS IN THE HEALTH-SYSTEM ENVIRONMENT TO IMPROVE MEDICATION-USE SAFETY, QUALITY OF CARE AND USE OF HEALTH CARE RESOURCES. THE FOURTH CLASS BEGAN IN JANUARY 2011 WITH 83 PARTICIPANTS. MAJOR PROGRAM ENHANCEMENTS WERE ACHIEVED IN FY11 WHEN THE PLA CURRICULUM WAS UPGRADED, THE MODULES WERE EXPANDED TO 6 WEEKS, WERE SWITCHED TO THE ECOLLEGE LEARNING MANAGEMENT SYSTEM, AND THE PROGRAM PARTNERED WITH MASTERS DEGREE PROGRAMS IN HEALTH CARE ADMINISTRATION AT SIMMONS COLLEGE IN BOSTON AND NEW ENGLAND COLLEGE IN NEW HAMPSHIRE. THE 2011 CLASS INCLUDED FOUR INTERNATIONAL PARTICIPANTS, ONE FROM THE BAHAMAS AND THREE FROM LEBANON. THE 2012 APPLICATION CYCLE ENDED ON AUGUST 12, 2011.LEADERSHIP LEARNING COMMUNITY-THE CENTER FOR HEALTH-SYSTEM PHARMACY LEADERSHIP HOSTED A SUCCESSFUL LEARNING COMMUNITY AT THE JUNE 2011 ASHP SUMMER MEETING ENTITLED "WILL, IDEAS AND EXECUTION: STRATEGIES FOR SUSTAINED RESULTS AND UNPRECEDENTED PERFORMANCE." THE 5-SESSION SERIES OFFERED MORE THAN 11 HOURS OF MATERIAL AND HAD AN ESTEEMED FACULTY OF SENIOR PHARMACISTS AND HEALTH-SYSTEM EXECUTIVES FROM A VARIETY OF HEALTH-SYSTEM SETTINGS. EDUCATIONAL SESSIONS ADDRESSED THE PHARMACY LEADER'S ROLE IN MAKING THE STATUS QUO UNCOMFORTABLE, ENHANCING WORKING RELATIONSHIPS TO GET THE JOB DONE AND ENSURING THAT THE PATIENT IS AT THE CENTER OF THE CARE PROCESS. THE PROGRAM WAS EXTREMELY WELL RECEIVED, AND EACH SESSION WAS WELL ATTENDED.PHARMACY LEADERSHIP INSTITUTE (PLI)-SINCE 2008 THE SECTION FOR PHARMACY PRACTICE MANAGERS HAS COLLABORATED WITH BOSTON UNIVERSITY TO ESTABLISH THE PLI AS A MAJOR PROGRAM WITHIN THE CENTER'S PORTFOLIO AND TO HAVE IT SERVE AS ITS CAPSTONE PROGRAM. THE PLI USES RELEVANT PROGRAM CURRICULUM, HIGH-QUALITY INSTRUCTION AND PEER INTERACTION TO BROADEN BUSINESS SKILLS, MANAGERIAL VERSATILITY AND THE EXTRAORDINARY LEADERSHIP DEMANDED OF TODAY'S HEALTH-SYSTEM PHARMACY LEADERS. THE EXPERIENCE ENABLES PHARMACIST LEADERS TO DEVELOP A NEW WAY OF THINKING AND A NEW SET OF BEHAVIORS TO MEET THE DEMANDING CHALLENGES FACING PHARMACY. PLI GRADUATES HAVE BECOME A SOURCE OF LEADERSHIP EXPERTS SERVING THE CENTER'S INITIATIVES. THE CENTER, WORKING WITH THE SUPPORT OF THE CARDINAL HEALTH FOUNDATION AND EXPERTISE OF THE BOSTON UNIVERSITY SCHOOL OF MANAGEMENT, CONCLUDED THE TWELFTH PROGRAM OFFERING IN APRIL 2011. TWENTY-NINE (29) HEALTH-SYSTEM PHARMACY LEADERS WERE SELECTED TO ATTEND THE WEEK-LONG EXECUTIVE TRAINING PROGRAM AND THREE-HUNDRED TWENTY (320) PHARMACISTS HAVE PARTICIPATED IN THE PROGRAM SINCE ITS INCEPTION. CONVERSATIONS WITH HEALTH-SYSTEM PHARMACY'S MOST INFLUENTIAL LEADERS VIDEOS-ASHP PAST PRESIDENT AND WHITNEY AWARD RECIPIENT SARA WHITE PROVIDED THE FOUNDATION WITH ONGOING FINANCIAL SUPPORT AND VOLUNTEERED HER TIME TO HELP PRODUCE A SERIES OF VIDEOS WITH SOME OF THE MOST INFLUENTIAL HEALTH-SYSTEM PHARMACY LEADERS. THE VIDEOS ARE HOSTED ON THE ASHP FOUNDATION WEBSITE AS A LEADERSHIP RESOURCE AND A SOURCE OF MOTIVATION FOR HEALTH-SYSTEM PHARMACY PROFESSIONALS. THREE NEW VIDEOS WERE ADDED IN THE FALL OF 2010 (JOHN A. GANS, LUCINDA MAINS AND PAUL G. PIERPAOLI), EXPANDING THE TOTAL NUMBER OF VIDEOS TO 12. THREE NEW VIDEOS ARE PLANNED FOR COMPLETION IN FY12, AND ALL OF THE VIDEOS WILL BE MADE AVAILABLE AS PODCASTS.LEADERSHIP SPEAKERS BUREAU (LSB)- THE LSB IS THE FIRST PROGRAM OF THE CENTER FOR HEALTH-SYSTEM PHARMACY LEADERSHIP DEVELOPED SPECIFICALLY FOR STUDENTS. PHARMACISTS WHO ARE ASHP STATE AFFILIATE MEMBERS ARE THE PRIMARY SPEAKERS. THEY DRAW UPON THEIR PERSONAL AND PROFESSIONAL EXPERIENCES TO ENCOURAGE STUDENTS TO EMBRACE LEADERSHIP AS PART OF THEIR PROFESSIONAL OBLIGATION. SPEAKERS HIGHLIGHT LEADERSHIP OPPORTUNITIES AND PRACTICE SUCCESS STORIES IN HEALTH-SYSTEM PHARMACY TO UNDERSCORE THE NEED FOR THIS COMMITMENT AS STUDENTS. THE STUDENT FORUM LEADERSHIP SECTION ADVISORY GROUP HAS BECOME AN ACTIVE PARTNER IN THE LSB'S PROMOTION AND EVALUATION. THE LSB HAS BEEN TRANSFORMED INTO AN ONLINE TOOL KIT TO INCREASE ITS ACCESSIBILITY AND IS LINKED TO THE STUDENT FORUM WEB PAGE. SUPPORTED BY A GRANT FROM ROCHE, THE CENTER HAS SET A TARGET OF 30 SCHOOLS OF PHARMACY TO PARTICIPATE IN THE PROGRAM DURING FY12. OTHER PROGRAMS:- COMMUNITY HEALTH SYSTEMS (CHS) LEADERSHIP SEMINAR SERIES- LEADERSHIP RESOURCE CENTER- WILLIAM A. ZELLMER LEADERSHIP LECTURE: WHERE PRACTICE MEETS POLICY- PGY-1 EXPANSION GRANT- STUDENT LEADERSHIP DEVELOPMENT WORKSHOP- PHARMACY STUDENT CLINICAL SKILLS COMPETITION- DEMONSTRATING PHARMACISTS' VALUE: A SYSTEMATIC EVIDENCE REVIEW- HARVEY A.K. WHITNEY AWARD LECTURE'S ONLINE COLLECTION PROGRAM- LITERATURE AWARDS PROGRAM- PHARMACY PRACTICE MODEL INITIATIVE (PPMI)- RESEARCH BOOT CAMP- STERILE PRODUCTS OUTSOURCING TOOL- ANTITHROMBOTIC ASSESSMENT TOOL- WALTER JONES MEMORIAL PHARMACY STUDENT FINANCIAL AID FUND AND THE ASHP STUDENT LEADERSHIP AWARD | Description |
Activity2 Activity2
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | 520548 | Expense |
| Grants | 128308 | Grants |
| Description | DESIGN AND STUDY OF SAFE AND EFFECTIVE MEDICATION-USE SYSTEMS:2010 AWARD FOR EXCELLENCE IN MEDICATION-USE SAFETY-SUPPORTED BY A GRANT FROM THE CARDINAL HEALTH FOUNDATION, THIS PROGRAM IS DESIGNED TO RECOGNIZE A PHARMACIST-LED MULTIDISCIPLINARY TEAM THAT MAKES SIGNIFICANT INSTITUTION-WIDE SYSTEM IMPROVEMENTS RELATING TO MEDICATION USE. THE PROGRAM IS IN ITS SEVENTH YEAR AND IS THE ONLY NATIONAL-LEVEL PROGRAM THAT RECOGNIZES THE PHARMACIST'S LEADERSHIP ROLE IN THE MEDICATION-USE PROCESS. THE THREE 2010 FINALIST ORGANIZATIONS WERE SELECTED FROM 16 APPLICANTS USING STRUCTURED SELECTION CRITERIA ESTABLISHED BY AN INDEPENDENT MULTIDISCIPLINARY PANEL OF EXPERTS IN THE FIELD OF MEDICATION SAFETY AND HEALTH-SYSTEM ADMINISTRATION. THE MEDICAL UNIVERSITY OF SOUTH CAROLINA IN CHARLESTON RECEIVED THE $50,000 AWARD. THE TWO FINALISTS, KINGSBROOK JEWISH MEDICAL CENTER IN BROOKLYN, N.Y., AND LANCASTER GENERAL HEALTH IN LANCASTER, PA., EACH RECEIVED $10,000. THE 2010 AWARD FOR EXCELLENCE VIDEO HIGHLIGHTED THE SUCCESS STORIES OF THE RECIPIENT AND FINALISTS AND WAS SHOWN TO MORE THAN 8,000 PHARMACISTS AT THE 2010 ASHP MIDYEAR CLINICAL MEETING OPENING GENERAL SESSION IN ANAHEIM, CALIF. A DINNER WAS ALSO HELD AT THE MIDYEAR TO RECOGNIZE THE FINALIST AND RECIPIENT TEAMS.THE MEDICAL UNIVERSITY OF SOUTH CAROLINA (MUSC) MEDICAL CENTER'S AWARD WINNING MEDICATION SAFETY INITIATIVE FOCUSED ON OPTIMIZING MEDICATION USE AND OUTCOMES IN KIDNEY TRANSPLANT PATIENTS. OVER AN 18-MONTH PERIOD, MUSC IMPLEMENTED A MULTISTEP INITIATIVE TO DECREASE HOSPITAL LENGTH OF STAY AND PREVENTABLE READMISSIONS FOR THESE PATIENTS WHILE OPTIMIZING PATIENT AND TRANSPLANTED ORGAN OUTCOMES. THEY REVISED KIDNEY TRANSPLANT PROTOCOLS, ESTABLISHED A DIABETES MANAGEMENT SERVICE TO MANAGE INPATIENT AND OUTPATIENT GLUCOSE CONTROL AND IMPLEMENTED INTENSIVE PATIENT AND CAREGIVER EDUCATION BEFORE AND AFTER DISCHARGE. THEY ALSO DEVELOPED A NEW PROCESS TO RECONCILE MEDICATIONS USED BEFORE AND AFTER TRANSPLANT AND STREAMLINED THE WAY THEY PROVIDE HOME MEDICATIONS TO PATIENTS. AS A RESULT, MUSC EXPERIENCED A 40-PERCENT REDUCTION IN MEDICATION ERRORS AND ADVERSE DRUG EVENTS, A 25-PERCENT REDUCTION IN ACUTE REJECTION RATES AND A 10-PERCENT DECREASE IN INFECTION RATES. MUSC ALSO REDUCED DELAYED DISCHARGES BY 14 PERCENT AND 7-DAY READMISSION RATES BY 50 PERCENT. MUSC'S INITIATIVE DEMONSTRATES THAT A SYSTEMATIC AND TEAM-BASED QUALITY IMPROVEMENT PROCESS FOCUSED ON A HIGH-RISK PATIENT POPULATION CAN IMPROVE QUALITY OF CARE AND PATIENT OUTCOMES.FOR THE FOURTH YEAR, THE ASHP FOUNDATION, WITH ASSISTANCE FROM ASHP, SPONSORED A NATIONAL RADIO MEDIA TOUR AIMED AT EDUCATING CONSUMERS ABOUT THE VITAL ROLE OF HEALTH-SYSTEM PHARMACISTS. THE RADIO MEDIA TOUR OCCURRED IN MARCH 2011 DURING NATIONAL PATIENT SAFETY AWARENESS WEEK. FOR THE TOUR, THERE WERE 19 TAPED AND LIVE INTERVIEWS, WHICH REACHED 576,000 LISTENERS. DR. NICOLE PILCH ALSO TAPED A RADIO NEWS RELEASE FOR NATIONAL PATIENT SAFETY AWARENESS WEEK THAT WAS AIRED BY APPROXIMATELY 779 STATIONS AND WAS HEARD BY 2.7 MILLION LISTENERS. IN ADDITION, DRS. PILCH AND DAVID TABER PRESENTED AN EDUCATIONAL SESSION AT THE 2011 ASHP SUMMER MEETING ENTITLED "MEDICATION SAFETY IN A HIGH-RISK PATIENT POPULATION: THE MUSC STORY."THE 2011 AWARD PROGRAM WAS LAUNCHED IN EARLY SPRING WITH PROMOTION TO HEALTH SYSTEMS ACROSS THE COUNTRY. FORTY-EIGHT APPLICATIONS WERE RECEIVED FOR THE 2011 PROGRAM. THE AWARD RECIPIENT AND FINALISTS WILL BE SELECTED IN AUGUST 2011.MEDICATION SAFETY TEAM GRANT: OPTIMIZING BEDSIDE TECHNOLOGY SOLUTIONS-THE THREE-YEAR COMMITMENT FROM OMNICELL TO SUPPORT THIS PROGRAM ENDED IN MAY 2009. RESEARCH BY THE 2009 RECIPIENTS IS ONGOING. DRS. ASHLEY DALTON, CRAIG FROST AND STEVEN ABEL PRESENTED THEIR FINDINGS AT THE 2010 ASHP MIDYEAR CLINICAL MEETING IN A SESSION ENTITLED "RESULTS FROM BCMA RESEARCH: A TALE OF THREE CITIES." DR. FROST'S STUDY, ENTITLED "EFFECT OF BAR-CODE-ASSISTED MEDICATION ADMINISTRATION ON NURSES' ACTIVITIES IN AN INTENSIVE CARE UNIT: A TIME-MOTION STUDY," WAS PUBLISHED IN THE AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. (SEE: DWIBEDI N, SANSGIRY SS, FROST CP, DASGUPTA A, JACOB SM, TIPTON JA, SHIPPY AA. EFFECT OF BAR-CODE-ASSISTED MEDICATION ADMINISTRATION ON NURSES' ACTIVITIES IN AN INTENSIVE CARE UNIT: A TIME-MOTION STUDY. AM J HEALTH SYST PHARM. 2011 JUN 1;68(11):1026-31.)THE OTHER GRANT RECIPIENTS FROM 2007 AND 2008 ARE PREPARING MANUSCRIPTS FOR PUBLICATION. MEDICATION CONTINUITY OF CARE RECORD RESEARCH (ALSO SUPPORTS STRATEGIC PRIORITY SP 2)-THIS PROGRAM EVALUATION ENTITLED "DEVELOPMENT OF A CONTINUITY OF CARE RECORD: BRIDGING THE MEDICATION-USE GAP FROM HOSPITAL TO HOME," IS BEING CONDUCTED BY KIM C. COLEY, PHARM.D., OF THE UNIVERSITY OF PITTSBURGH SCHOOL OF PHARMACY. THIS STUDY IS SUPPORTED BY SANOFI AVENTIS. DR. COLEY IS STUDYING THE USE OF A CONTINUITY OF CARE RECORD AND MEDICATION THERAPY MANAGEMENT IN THE TRANSITION OF PATIENTS FROM HOSPITAL TO HOME. PREPARATION OF THE FIRST TWO MANUSCRIPTS FROM THIS STUDY, A REPORT ON THE TOOL DEVELOPMENT AND A HYPOTHESIS-GENERATING CASE SERIES, IS UNDERWAY. THIS STUDY IS BEING MODIFIED TO INCLUDE A FOCUS GROUP COMPONENT THAT WILL BE USED TO ENHANCE THE CONTINUITY OF CARE TOOL.PANDEMIC INFLUENZA ASSESSMENT TOOL (ALSO SUPPORTS SP 2 AND 3)-ROCHE PROVIDED A GRANT TO DEVELOP A PANDEMIC READINESS AND EMERGENCY PREPAREDNESS RESOURCE CENTER WHICH IS AVAILABLE AT WWW.PHARMACYREADY.ORG. THIS SITE CONTAINS THE PANDEMIC INFLUENZA ASSESSMENT TOOL FOR HEALTH-SYSTEM PHARMACY DEPARTMENTS (TM) ALONG WITH PRACTICE RESOURCES, RSS FEEDS AND BENCHMARKING DATA. BETWEEN JUNE 2009 AND MAY 2010, DURING AN H1N1 INFLUENZA PANDEMIC, THERE WERE MORE THAN 150,000 VISITS TO THIS WEB-BASED TOOL. THE TOOL CONTINUES TO BE USED DESPITE THE ABSENCE OF A CURRENT PANDEMIC INFLUENZA THREAT. THIS RESOURCE CONTINUES TO RECEIVE A SUBSTANTIAL NUMBER OF VISITORS ON A MONTHLY BASIS. | Description |
Activity3 Activity3
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | 478824 | Expense |
| Grants | 133997 | Grants |
| Description | ADVANCEMENT OF OPTIMAL PATIENT MEDICATION OUTCOMES:ASHP FDTN JUNIOR INVESTIGATOR RESEARCH GRANT (ALSO SUPPORTS SP 3)-EIGHTEEN APPLICATIONS WERE RECEIVED FOR THE ASHP FOUNDATION JUNIOR INVESTIGATOR RESEARCH GRANT DURING THE FY11 CYCLE. THIS GRANT IS OFFERED TO NEW PHARMACIST INVESTIGATORS AND IS INTENDED TO SUPPORT PRACTICE-BASED MEDICATION-USE RESEARCH. GRANT FUNDS ARE PROVIDED BY THE ASHP FOUNDATION THROUGH JOSEPH A. ODDIS ENDOWMENT. A SEVEN-MEMBER REVIEW PANEL COMPOSED OF PHARMACIST AND PHYSICIAN RESEARCHERS RECOMMENDED AWARD OF THE FOLLOWING GRANTS: "PHARMACODYNAMIC ANALYSIS OF VANCOMYCIN BASED ON PATIENT-SPECIFIC PROTEIN BINDING," WHICH WILL BE CONDUCTED BY JARED L. CRANDON, PHARM.D., AND DAVID P. NICOLAU, PHARM.D., OF HARTFORD HOSPITAL AND "COMPARISON OF IMMUNE RESPONSE TO THE INFLUENZA VACCINE IN OBESE AND NON-OBESE HEALTHCARE WORKERS," WHICH WILL BE CONDUCTED BY MICHAEL A. SWEET, PHARM.D., OF WEST VIRGINIA UNIVERSITY HOSPITALS, AND RASHIDA A. KHAKOO, M.D., OF THE WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE. STUDIES FUNDED DURING THE FY09 AND FY10 GRANT CYCLES PROGRESSED DURING FY11. 2009 RECIPIENT DR. LETICIA MOCZYGEMBA RECEIVED THE 2011 BEST NEW INVESTIGATOR PODIUM RESEARCH PRESENTATION AWARD FROM THE INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS AND OUTCOMES RESEARCH (ISPOR) FOR PRESENTATION OF HER STUDY ENTITLED "12-MONTH OUTCOMES OF A PHARMACIST-PROVIDED TELEPHONE MEDICATION THERAPY." RESEARCH FROM THE 2010 PROGRAM IS ONGOING. AMERICAN FOUNDATION FOR PHARMACEUTICAL EDUCATION (AFPE) PRE-DOCTORAL FELLOWSHIP- THE ASHP FOUNDATION PARTNERED WITH ASHP TO SUPPORT ANNUAL FUNDING OF $7,500 FOR THE 2010 AFPE PRE-DOCTORAL FELLOWSHIP PROGRAM. THE ASHP/ASHP FOUNDATION SCHOLARSHIP WAS AWARDED TO DEANNA S. FLORA, A PH.D. CANDIDATE IN CLINICAL PHARMACEUTICAL SCIENCE AT VIRGINIA COMMONWEALTH UNIVERSITY COLLEGE OF PHARMACY. HER DISSERTATION TOPIC IS "DRUG BURDEN AND COGNITION IN COMMUNITY-DWELLING OLDER ADULTS."ANTITHROMBOTIC PHARMACOTHERAPY TRAINEESHIP PROGRAM-IN COLLABORATION WITH ASHP AS PART OF A MULTI TIERED EDUCATIONAL PROGRAM, THE FOUNDATION RECEIVED FUNDING FOR THE 2009/2010 ANTITHROMBOTIC PHARMACOTHERAPY TRAINEESHIP FROM SANOFI-AVENTIS. THE 2009/2010 PROGRAM OFFERING WAS REVISED TO INCLUDE A COMPREHENSIVE WEB-BASED DISTANCE EDUCATION PROGRAM AND COMPARISON OF ANTITHROMBOTIC MEDICATION-RELATED PRE/POST-PROCESS AND PATIENT OUTCOMES. THE TRAINEESHIP CONCLUDED WITH A 5-DAY STRUCTURED EXPERIENTIAL PROGRAM THAT PREPARED PHARMACISTS TO ESTABLISH AND MAINTAIN SPECIALIZED SERVICES FOR THE MANAGEMENT OF PATIENTS' ANTITHROMBOTIC THERAPY. TWENTY-NINE TRAINEES WERE SELECTED FROM 31 APPLICANTS FOR THE 2009 PROGRAM, WITH 11 TRAINEES PARTICIPATING IN SESSION I AND 18 PARTICIPATING IN SESSION II. THE ASHP FOUNDATION TRACKED PROCESS AND PATIENT POPULATION OUTCOMES FOR EACH TRAINEE OVER A 1-YEAR PERIOD OF TIME. POSITIVE PATIENT CARE AND PROCESS EFFECTS WERE OBSERVED IN ESTABLISHMENT OF SERVICES IN THE INPATIENT AND OUTPATIENT SETTING. CRITICAL CARE TRAINEESHIP PROGRAM- PLANS ARE UNDERWAY TO ESTABLISH AN EXPERT PANEL TO REVISE THE CURRICULUM FOR THIS TRAINEESHIP IN EARLY WINTER 2011. THIS TRAINEESHIP WILL BE CONSIDERED FOR INCLUSION IN THE TUITION-BASED TRAINEESHIP MODEL THAT IS CURRENTLY BEING CONSIDERED. FEDERAL SERVICES JUNIOR INVESTIGATOR GRANT PROGRAM: OPTIMIZING CHRONIC DRUG THERAPY IN THE ELDERLY-FOUR APPLICATIONS WERE RECEIVED FOR THE ASHP FOUNDATION FEDERAL SERVICES JUNIOR INVESTIGATOR GRANT PROGRAM DURING THE MOST RECENT CYCLE. THIS GRANT IS OFFERED TO NEW PHARMACIST INVESTIGATORS AND IS INTENDED TO SUPPORT PRACTICE-BASED RESEARCH THAT FOCUSES ON OPTIMIZATION OF CHRONIC MEDICATION USE IN PATIENTS GREATER THAN 60 YEARS OF AGE. GRANT FUNDS ARE PROVIDED BY THE ASHP FOUNDATION THROUGH THE SUPPORT OF NOVARTIS. A FOUR-MEMBER REVIEW PANEL COMPOSED OF PHARMACIST AND PHYSICIAN RESEARCHERS RECOMMENDED AWARD OF THE FOLLOWING GRANTS: "EFFECT OF VIDEO-CONSULTATION ON MEDICATION ADHERENCE AND CLINICAL HEALTH OUTCOMES IN ELDERLY ALASKA NATIVES AND AMERICAN INDIANS IN RURAL ALASKA," WHICH WILL BE CONDUCTED BY SARA DORAN-ATCHISON, PHARM.D., OF THE ALASKAN NATIVE TRIBAL HEALTH CONSORTIUM, AND RENEE ROBISON, PHARM.D., OF THE SOUTHCENTRAL FOUNDATION; "A PILOT STUDY TO EVALUATE A TELEPHARMACY INTERVENTION TO IMPROVE INHALER ADHERENCE IN VETERANS WITH COPD," WHICH WILL BE CONDUCTED BY AMANDA R. MARGOLIS, PHARM.D., AND CHRISTINE SORKNESS, PHARM.D. OF THE UW-MADISON SCHOOL OF PHARMACY AND "A PROSPECTIVE EVALUATION OF A MEDICATION THERAPY MANAGEMENT CLINIC VERSUS USUAL MEDICAL CARE IN PATIENTS POST ACUTE CORONARY SYNDROME: THE MUMPS STUDY" WHICH WILL BE CONDUCTED BY CASSANDRA D. BENGE, PHARM.D., AND JAMES ANTHONY S. MULDOWNEY, M.D., OF TENNESSEE VALLEY HEALTH CARE SYSTEM PHARMACY. RESEARCH FUNDED DURING THE FY08 AND FY09 CYCLES CONTINUES TO BE ONGOING.2007 RECIPIENT, DR. KRISTEN SCHMITT OF THE CINCINNATI VA MEDICAL CENTER AND UNIVERSITY OF CINCINNATI COLLEGE OF PHARMACY, PUBLISHED HER RESEARCH REGARDING THE USE OF ANTIHYPERTENSIVE AGENTS IN PATIENTS WITH CHRONIC KIDNEY DISEASE. (SEE: SCHMITT KE, EDIE CF, LAFLAM P, SIMBARTL LA, THAKAR CV. ADHERENCE TO ANTIHYPERTENSIVE AGENTS AND BLOOD PRESSURE CONTROL IN CHRONIC KIDNEY DISEASE. AM J NEPHROL. 2010;32(6):541-8. EPUB 2010 NOV 2.)HOSPITAL PHARMACIST - HOSPITALIST COLLABORATIONS (ALSO SUPPORTS SP 3)-SANOFI-AVENTIS PROVIDED SPONSORSHIP FOR THIS PROGRAM THAT STUDIES MULTIDISCIPLINARY INITIATIVES BETWEEN HOSPITALISTS AND HOSPITAL PHARMACISTS FOCUSED ON VENOUS THROMBOEMBOLISM PREVENTION/TREATMENT OR GLYCEMIC CONTROL IN HOSPITALIZED PATIENTS. DRS. JEFFREY KETZ OF THE CLEVELAND CLINIC AND DR. KEVIN BOX OF THE UNIVERSITY OF CALIFORNIA, SAN DIEGO PRESENTED THEIR RESEARCH FINDINGS IN A JOINT SESSION AT THE 2010 ASHP MIDYEAR CLINICAL MEETING. DR. KETZ ALSO PRESENTED HIS RESEARCH AT THE 2011 SOCIETY FOR HOSPITAL MEDICINE ANNUAL MEETING. EMERGENCY PHYSICIAN/HOSPITAL PHARMACIST RESEARCH GRANT PROGRAM (ALSO SUPPORTS SP 3)-ORTHO-MCNEIL PROVIDED SPONSORSHIP FOR THIS PROGRAM WHICH SUPPORTS RESEARCH CONDUCTED BY HOSPITAL PHARMACISTS AND EMERGENCY PHYSICIANS RELATED TO THE CARE OF PATIENTS WITH INFECTIOUS DISEASES WHO PRESENT TO THE EMERGENCY DEPARTMENT. A 10-MEMBER REVIEW PANEL COMPOSED OF PHARMACISTS AND EMERGENCY PHYSICIANS RECOMMENDED AWARD OF THE FOLLOWING GRANTS: "ED PHARMACISTS OPTIMIZE ANTIMICROBIAL USE PROCESS IN SEVERE SEPSIS AND SEPTIC SHOCK," WHICH WILL BE CONDUCTED BY MARIA I. RUDIS, PHARM.D., AND CHRISTOPHER S. RUSSI, D.O., OF MAYO CLINIC ROCHESTER; "THE VALUE OF MRSA NARES CARRIAGE STATUS FOR TREATMENT OF SKIN AND SOFT INFECTIONS IN THE EMERGENCY DEPARTMENT," WHICH WILL BE CONDUCTED BY NICOLE M. ACQUISTO, PHARM.D., AND SHARON G. HUMISTON, M.D., M.P.H., OF THE UNIVERSITY OF ROCHESTER MEDICAL CENTER. THE PROPOSED RESEARCH IS ONGOING AS SCHEDULED AT THE RESPECTIVE SITES. ONCOLOGY PATIENT CARE TRAINEESHIP PROGRAM-SUPPORT FOR THE 2011 PROGRAM WAS PROVIDED BY AMGEN. EIGHT TRAINEES WERE SELECTED FROM 33 APPLICANTS. DISTANCE EDUCATION COMMENCED IN FEBRUARY 2011. PARTICIPANTS WILL RECEIVE THEIR EXPERIENTIAL TRAINING AT THE FOLLOWING THREE SITES BETWEEN AUGUST AND NOVEMBER 2011: THE JOHNS HOPKINS HOSPITAL, UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER, AND THE UNIVERSITY OF WASHINGTON MEDICAL CENTER. PAIN AND PALLIATIVE CARE TRAINEESHIP PROGRAM-ENDO PHARMACEUTICALS PROVIDED SUPPORT FOR A REDESIGN OF THE FORMER PAIN MANAGEMENT TRAINEESHIP TO INCLUDE PALLIATIVE CARE AND TO TRANSFORM THE DISTANCE EDUCATION COMPONENT TO REACH MORE PHARMACISTS. THE DISTANCE EDUCATION PROGRAM WILL INCLUDE A PAIN MANAGEMENT AND PALLIATIVE CARE SELF-ASSESSMENT TOOL AND MODULES TO ADDRESS APPLICATION OF THE PRINCIPLES OF PAIN MANAGEMENT AND PALLIATIVE CARE. DR. MARY LYNN MCPHERSON OF THE UNIVERSITY OF MARYLAND HAS BEEN ENGAGED TO SUPPORT THE CONTENT REDESIGN. ADDITIONAL FACULTY HAS BEEN RECRUITED FOR LEVEL 2. DEVELOPMENT OF CONTENT FOR LEVELS 1 AND 2 WAS ONGOING FROM OCTOBER 2010 THROUGH MAY 2011. FOLLOWING REDESIGN, TEN INDIVIDUALS WHO COMPLETE THE DISTANCE EDUCATION COMPONENTS WILL BE SELECTED TO PARTICIPATE IN ONSITE TRAINING AT FIVE HEALTH SYSTEMS ACROSS THE U.S.OTHER PROGRAMS:- PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAM- PHARMACY RESIDENT PRACTICE-BASED RESEARCH GRANT PROGRAM- PROMOTING INFLUENZA PREVENTION: PHARMACISTS AS IMMUNIZATION ADVOCATES- MULTICENTER MEDICATION RECONCILIATION QUALITY IMPROVEMENT STUDY (MARQUIS)- UNIVERSITY OF ALABAMA MUSCULOSKELETAL CERTS- MULTISITE UNSOLICITED GRANT | Description |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Expense | 2101539 | TotalProgramServiceExpense |
| Described In501 C3 | 1 | DescribedIn501C3 |
| Schedule B Required | 1 | ScheduleBRequired |
| Political Activities | 0 | PoliticalActivities |
| Lobbying Activities | 0 | LobbyingActivities |
| Donor Advised Funds | 0 | DonorAdvisedFunds |
| Conservation Easements | 0 | ConservationEasements |
| Collections Of Art | 0 | CollectionsOfArt |
| Credit Counseling | 0 | CreditCounseling |
| Term Or Permanent Endowments | 1 | TermOrPermanentEndowments |
| Report Land Bldg Equip | 1 | ReportLandBldgEquip |
| Report Invest Oth Securities | 0 | ReportInvestOthSecurities |
| Report Prog Rel Invest | 0 | ReportProgRelInvest |
| Report Other Assets | 0 | ReportOtherAssets |
| Report Other Liabilities | 1 | ReportOtherLiabilities |
| Report Fin48 Footnote | 1 | ReportFin48Footnote |
| Independent Audit Financial Stmt | 1 | IndependentAuditFinancialStmt |
| Consolidated Audit Financial Stmt | 0 | ConsolidatedAuditFinancialStmt |
| School | 0 | School |
| Foreign Office | 0 | ForeignOffice |
| Foreign Activities | 0 | ForeignActivities |
| More Than5000 K To Organizations | 0 | MoreThan5000KToOrganizations |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividuals |
| Professional Fundraising | 0 | ProfessionalFundraising |
| Fundraising Activities | 1 | FundraisingActivities |
| Gaming | 0 | Gaming |
| Hospital | 0 | Hospital |
| Grants To Organizations | 1 | GrantsToOrganizations |
| Grants To Individuals | 1 | GrantsToIndividuals |
| Schedule J Required | 1 | ScheduleJRequired |
| Tax Exempt Bonds | 0 | TaxExemptBonds |
| Excess Benefit Transaction | 0 | ExcessBenefitTransaction |
| Prior Excess Benefit Transaction | 0 | PriorExcessBenefitTransaction |
| Loan To Officer Or DQP | 0 | LoanToOfficerOrDQP |
| Grant To Related Person | 0 | GrantToRelatedPerson |
| Bsnss Rltnshp With Organization | 0 | BsnssRltnshpWithOrganization |
| Bsnss Rltnshp Thru Family Member | 0 | BsnssRltnshpThruFamilyMember |
| Officer Entity With Bsnss Rltnshp | 0 | OfficerEntityWithBsnssRltnshp |
| Deductible Non Cash Contributions | 1 | DeductibleNonCashContributions |
| Deductible Contributions Of Art | 0 | DeductibleContributionsOfArt |
| Terminated | 0 | Terminated |
| Partial Liquidation | 0 | PartialLiquidation |
| Disregarded Entity | 0 | DisregardedEntity |
| Related Entity | 1 | RelatedEntity |
| Related Org Controlled Entity | 0 | RelatedOrgControlledEntity |
| Transaction Related Entity | 0 | TransactionRelatedEntity |
| Transfers To Exempt Non Chrtbl Org | 1 | TransfersToExemptNonChrtblOrg |
| Activities Conducted Partnership | 0 | ActivitiesConductedPartnership |
| Schedule O Required | 1 | ScheduleORequired |
| Number Forms Transmitted With1096 | 87 | NumberFormsTransmittedWith1096 |
| Number W2 G Included | 0 | NumberW2GIncluded |
| Compliance With Backup Witholding | 1 | ComplianceWithBackupWitholding |
| Number Of Employees | 0 | NumberOfEmployees |
| Unrelated Business Income | 0 | UnrelatedBusinessIncome |
| Foreign Financial Account | 0 | ForeignFinancialAccount |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTrans |
| Taxable Party Notification | 0 | TaxablePartyNotification |
| Non Deductible Contributions | 0 | NonDeductibleContributions |
| Quid Pro Quo Contributions | 1 | QuidProQuoContributions |
| Quid Pro Quo Disclosure | 1 | QuidProQuoDisclosure |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOf |
| Funds To Pay Premiums | 0 | FundsToPayPremiums |
| Premiums Paid | 0 | PremiumsPaid |
| Indoor Tanning Services | 0 | IndoorTanningServices |
| Info In Schedule O Part VI | X | InfoInScheduleOPartVI |
| Nbr Voting Governing Body Members | 10 | NbrVotingGoverningBodyMembers |
| Number Independent Voting Members | 8 | NumberIndependentVotingMembers |
| Family Or Business Relationship | 1 | FamilyOrBusinessRelationship |
| Delegation Of Management Duties | 0 | DelegationOfManagementDuties |
| Changes To Organizing Docs | 0 | ChangesToOrganizingDocs |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuse |
| Members Or Stockholders | 0 | MembersOrStockholders |
| Election Of Board Members | 1 | ElectionOfBoardMembers |
| Decisions Subject To Approval | 0 | DecisionsSubjectToApproval |
| Minutes Of Governing Body | 1 | MinutesOfGoverningBody |
| Minutes Of Committees | 0 | MinutesOfCommittees |
| Officer Mailing Address | 0 | OfficerMailingAddress |
| Local Chapters | 0 | LocalChapters |
| Form990 Provided To Governing Body | 1 | Form990ProvidedToGoverningBody |
| Conflict Of Interest Policy | 1 | ConflictOfInterestPolicy |
| Annual Disclosure Covered Persons | 1 | AnnualDisclosureCoveredPersons |
| Regular Monitoring Enforcement | 1 | RegularMonitoringEnforcement |
| Whistleblower Policy | 1 | WhistleblowerPolicy |
| Document Retention Policy | 1 | DocumentRetentionPolicy |
| Compensation Process CEO | 1 | CompensationProcessCEO |
| Compensation Process Other | 0 | CompensationProcessOther |
| Investment In Joint Venture | 0 | InvestmentInJointVenture |
| States Where Copy Of Return Is Filed | MD | StatesWhereCopyOfReturnIsFiled |
| Upon Request | X | UponRequest |
The Books Are In Care Of TheBooksAreInCareOf
Name Business NameBusiness
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ELIZABETH HARTNETT | BusinessNameLine1 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Telephone Number | 3016648612 | TelephoneNumber |
Address US AddressUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 7272 WISCONSIN AVENUE 2ND FLOOR | AddressLine1 |
| City | BETHESDA | City |
| State | MD | State |
| ZIP Code | 20814 | ZIPCode |
Form990 Part VII Section A Form990PartVIISectionA (15 entries)
| TitleTitle | Average Hours Per WeekAverageHoursPerWeek | Individual Trustee Or DirectorIndividualTrusteeOrDirector | OfficerOfficer | Reportable Comp From OrganizationReportableCompFromOrganization | Reportable Comp From Related OrgsReportableCompFromRelatedOrgs | Other CompensationOtherCompensation | Highest Compensated EmployeeHighestCompensatedEmployee |
|---|---|---|---|---|---|---|---|
| KEVIN J COLGAN MA FASHP | |||||||
| CHAIR | 1.00 | X | X | 0 | 0 | 0 | |
| DAVID R GAUGH | |||||||
| VICE CHAIR | 1.00 | X | X | 0 | 0 | 0 | |
| HENRI R MANASSE JR PHD SCD | |||||||
| PRESIDENT/ASHP EVP-CEO | 1.00 | X | X | 0 | 746154 | 76276 | |
| PHILIP J SCHNEIDER BS PHARMD | |||||||
| TREASURER | 1.00 | X | X | 0 | 0 | 0 | |
| STEPHEN J ALLEN MS FASHP | |||||||
| SECRETARY/EVP-CEO | 40.00 | X | X | 240214 | 0 | 30422 | |
| BARBARA BALIK RN MS EDD | |||||||
| DIRECTOR AT LARGE | 1.00 | X | 0 | 0 | 0 | ||
| MICK L HUNT MS MBA FASHP | |||||||
| DIRECTOR AT LARGE | 1.00 | X | 0 | 0 | 0 | ||
| MICHAEL S FLAGSTAD MS RPH | |||||||
| DIRECTOR AT LARGE | 1.00 | X | 0 | 0 | 0 | ||
| LYNNAE M MAHANEY MBA FASHP | |||||||
| DIRECTOR AT LARGE | 1.00 | X | 0 | 10000 | 0 | ||
| BRUCE E SCOTT PHARMD FASHP | |||||||
| DIRECTOR AT LARGE | 1.00 | X | 0 | 0 | 0 | ||
| DALLAS J HOWE | |||||||
| DIRECTOR AT LARGE | 1.00 | X | 0 | 0 | 0 | ||
| GORDON S WILLCOX | |||||||
| DIRECTOR AT LARGE | 1.00 | X | 0 | 0 | 0 | ||
| DANIEL COBAUGH | |||||||
| VICE PRESIDENT | 40.00 | 161174 | 0 | 22820 | X | ||
| RICHARD WALLING | |||||||
| DIRECTOR, CTR FOR HLTH-SYS PHARM LDRSHP | 40.00 | 148484 | 0 | 12973 | X | ||
| MYRNA KONAJESKI | |||||||
| DIRECTOR OF DEVELOPMENT | 40.00 | 106899 | 0 | 21441 | X | ||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | 656771 | TotalReportableCompFromOrg |
| Total Reportable Comp Frm Rltd Orgs | 756154 | TotalReportableCompFrmRltdOrgs |
| Total Other Compensation | 163932 | TotalOtherCompensation |
| Number Individuals GT100 K | 4 | NumberIndividualsGT100K |
| Formers Listed | 0 | FormersListed |
| Total Comp GT150 K | 1 | TotalCompGT150K |
| Compensation From Other Sources | 0 | CompensationFromOtherSources |
Contractor Compensation ContractorCompensation
Name Of Contractor NameOfContractor
Name Business NameBusiness
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ENVISION CHANGE LLC | BusinessNameLine1 |
Address Of Contractor AddressOfContractor
Address US AddressUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 3324D WEST CARY STREET | AddressLine1 |
| City | RICHMOND | City |
| State | VA | State |
| ZIP Code | 23221 | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Description Of Services | CONSULTING | DescriptionOfServices |
| Compensation | 111483 | Compensation |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Number Of Contractors GT100 K | 1 | NumberOfContractorsGT100K |
| Fundraising Events | 27315 | FundraisingEvents |
| All Other Contributions | 2670187 | AllOtherContributions |
| Total Contributions | 2697502 | TotalContributions |
Program Service Revenue ProgramServiceRevenue
| Field | Value | IRS element (for citing) |
|---|---|---|
| Description | PHARMACY LEADERSHIP AC | Description |
| Business Code | 900099 | BusinessCode |
| Total Revenue Column | 216540 | TotalRevenueColumn |
| Related Or Exempt Function Income | 216540 | RelatedOrExemptFunctionIncome |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | 216540 | TotalProgramServiceRevenue |
Investment Income InvestmentIncome
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 232970 | TotalRevenueColumn |
| Exclusion | $232,970 | ExclusionAmount |
Gross Amount Sales Assets GrossAmountSalesAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | 1095594 | Securities |
| Other | 47409 | Other |
Less Cost Oth Basis Sales Expenses LessCostOthBasisSalesExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other | 60800 | Other |
Gain Or Loss GainOrLoss
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | 1095594 | Securities |
| Other | -13391 | Other |
Net Gain Or Loss Investments NetGainOrLossInvestments
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 1082203 | TotalRevenueColumn |
| Exclusion | $1,082,203 | ExclusionAmount |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Income Fundraising Events | 7085 | GrossIncomeFundraisingEvents |
| Cntrbtns Rprtd Fundraising Events | 27315 | CntrbtnsRprtdFundraisingEvents |
| Fundraising Direct Expenses | 14276 | FundraisingDirectExpenses |
Net Income From Fundraising Events NetIncomeFromFundraisingEvents
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -7191 | TotalRevenueColumn |
| Exclusion | -$7,191 | ExclusionAmount |
Total Revenue TotalRevenue
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 4222024 | TotalRevenueColumn |
| Related Or Exempt Function Income | 216540 | RelatedOrExemptFunctionIncome |
| Unrelated Business Revenue | 0 | UnrelatedBusinessRevenue |
| Exclusion | $1,307,982 | ExclusionAmount |
Grants To Domestic Orgs GrantsToDomesticOrgs
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 269944 | Total |
| Program Services | 269944 | ProgramServices |
Grants To Domestic Individuals GrantsToDomesticIndividuals
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 79533 | Total |
| Program Services | 79533 | ProgramServices |
Comp Current Officers Directors CompCurrentOfficersDirectors
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 275172 | Total |
| Program Services | 189739 | ProgramServices |
| Management And General | 11264 | ManagementAndGeneral |
| Fundraising | 74169 | Fundraising |
Other Salaries And Wages OtherSalariesAndWages
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 730698 | Total |
| Program Services | 501090 | ProgramServices |
| Management And General | 26523 | ManagementAndGeneral |
| Fundraising | 203085 | Fundraising |
Pension Plan Contributions PensionPlanContributions
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 73975 | Total |
| Program Services | 49751 | ProgramServices |
| Management And General | 5764 | ManagementAndGeneral |
| Fundraising | 18460 | Fundraising |
Other Employee Benefits OtherEmployeeBenefits
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 45214 | Total |
| Program Services | 27377 | ProgramServices |
| Management And General | 2398 | ManagementAndGeneral |
| Fundraising | 15439 | Fundraising |
Payroll Taxes PayrollTaxes
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 53540 | Total |
| Program Services | 43494 | ProgramServices |
| Management And General | 3956 | ManagementAndGeneral |
| Fundraising | 6090 | Fundraising |
Fees For Services Accounting FeesForServicesAccounting
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 9600 | Total |
| Management And General | 9600 | ManagementAndGeneral |
Fees For Services Other FeesForServicesOther
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 634990 | Total |
| Program Services | 539920 | ProgramServices |
| Management And General | 62057 | ManagementAndGeneral |
| Fundraising | 33013 | Fundraising |
Office Expenses OfficeExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 15056 | Total |
| Program Services | 9812 | ProgramServices |
| Management And General | 1330 | ManagementAndGeneral |
| Fundraising | 3914 | Fundraising |
Occupancy Occupancy
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 59691 | Total |
| Program Services | 32851 | ProgramServices |
| Management And General | 12509 | ManagementAndGeneral |
| Fundraising | 14331 | Fundraising |
Travel Travel
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 263690 | Total |
| Program Services | 233471 | ProgramServices |
| Management And General | 27349 | ManagementAndGeneral |
| Fundraising | 2870 | Fundraising |
Depreciation Depletion DepreciationDepletion
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 24806 | Total |
| Program Services | 14263 | ProgramServices |
| Management And General | 10543 | ManagementAndGeneral |
Other Expenses OtherExpenses (5 entries)
| DescriptionDescription | TotalTotal | Program ServicesProgramServices | Management And GeneralManagementAndGeneral | FundraisingFundraising |
|---|---|---|---|---|
| GENERAL EXPENSES | 146543 | 115471 | 3331 | 27741 |
| TEMPORARY SERVICES | 17600 | 8800 | 2640 | 6160 |
| BANK CHARGES | 2473 | 2473 | ||
| STAFF DEVELOPMENT | 1812 | 299 | 823 | 690 |
| SPECIAL EVENT EXPENSE T | -14276 | -14276 |
Total Functional Expenses TotalFunctionalExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 2690061 | Total |
| Program Services | 2101539 | ProgramServices |
| Management And General | 182560 | ManagementAndGeneral |
| Fundraising | 405962 | Fundraising |
Savings And Temp Cash Investments SavingsAndTempCashInvestments
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 1019149 | BOY |
| EOY | 2073427 | EOY |
Pledges And Grants Receivable PledgesAndGrantsReceivable
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 214572 | BOY |
| EOY | 197662 | EOY |
Prepaid Expenses Deferred Charges PrepaidExpensesDeferredCharges
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 9325 | BOY |
| EOY | 1847 | EOY |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Buildings Equipment Basis | 136358 | LandBuildingsEquipmentBasis |
| Land Bldg Equipment Accum Deprec | 107479 | LandBldgEquipmentAccumDeprec |
Land Buildings Equipment Basis Net LandBuildingsEquipmentBasisNet
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 65332 | BOY |
| EOY | 28879 | EOY |
Investments Pub Traded Securities InvestmentsPubTradedSecurities
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 8377415 | BOY |
| EOY | 9058798 | EOY |
Other Assets Total OtherAssetsTotal
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 146458 | BOY |
| EOY | 121588 | EOY |
Total Assets TotalAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 9832251 | BOY |
| EOY | 11482201 | EOY |
Accounts Payable Accrued Expenses AccountsPayableAccruedExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 194520 | BOY |
| EOY | 182577 | EOY |
Deferred Revenue DeferredRevenue
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 77184 | BOY |
| EOY | 152829 | EOY |
Other Liabilities OtherLiabilities
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 0 | BOY |
| EOY | 54285 | EOY |
Total Liabilities TotalLiabilities
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 271704 | BOY |
| EOY | 389691 | EOY |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Follow SFAS117 | X | FollowSFAS117 |
Unrestricted Net Assets UnrestrictedNetAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 1869549 | BOY |
| EOY | 2060723 | EOY |
Temporarily Restricted Net Assets TemporarilyRestrictedNetAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 2912954 | BOY |
| EOY | 4253393 | EOY |
Permanently Restricted Net Assets PermanentlyRestrictedNetAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 4778044 | BOY |
| EOY | 4778394 | EOY |
Total Net Assets Fund Balances TotalNetAssetsFundBalances
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 9560547 | BOY |
| EOY | 11092510 | EOY |
Total Liab Net Assets Fund Balances TotalLiabNetAssetsFundBalances
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 9832251 | BOY |
| EOY | 11482201 | EOY |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expenses | 1531963 | ReconcilationRevenueExpenses |
| Reconcilation Other Changes | 0 | ReconcilationOtherChanges |
| Method Of Accounting Accrual | X | MethodOfAccountingAccrual |
| Accountant Compile Or Review | 0 | AccountantCompileOrReview |
| FS Audited | 1 | FSAudited |
| Audit Committee | 0 | AuditCommittee |
| Financial Statement Separate | X | FinancialStatementSeparate |
| Federal Grant Audit Required | 0 | FederalGrantAuditRequired |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Publicly Supported Org170b1 Avi | X | PubliclySupportedOrg170b1Avi |
Gifts Grants Contrib Received170 GiftsGrantsContribReceived170
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | 1606236 | CurrentTaxYearMinus4Years |
| Current Tax Year Minus3 Years | 1802114 | CurrentTaxYearMinus3Years |
| Current Tax Year Minus2 Years | 1610656 | CurrentTaxYearMinus2Years |
| Current Tax Year Minus1 Year | 1993575 | CurrentTaxYearMinus1Year |
| Current Tax Year | 2697502 | CurrentTaxYear |
| Total | 9710083 | Total |
Total170 Total170
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | 1606236 | CurrentTaxYearMinus4Years |
| Current Tax Year Minus3 Years | 1802114 | CurrentTaxYearMinus3Years |
| Current Tax Year Minus2 Years | 1610656 | CurrentTaxYearMinus2Years |
| Current Tax Year Minus1 Year | 1993575 | CurrentTaxYearMinus1Year |
| Current Tax Year | 2697502 | CurrentTaxYear |
| Total | 9710083 | Total |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Amounts Subst Contributors Total | 4658390 | AmountsSubstContributorsTotal |
| Public Support Total170 | 5051693 | PublicSupportTotal170 |
Gross Investment Income170 GrossInvestmentIncome170
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | 357682 | CurrentTaxYearMinus4Years |
| Current Tax Year Minus3 Years | 307359 | CurrentTaxYearMinus3Years |
| Current Tax Year Minus2 Years | 299628 | CurrentTaxYearMinus2Years |
| Current Tax Year Minus1 Year | 234578 | CurrentTaxYearMinus1Year |
| Current Tax Year | 232970 | CurrentTaxYear |
| Total | 1432217 | Total |
Other Income170 OtherIncome170
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | 36582 | CurrentTaxYearMinus4Years |
| Current Tax Year Minus3 Years | 6720 | CurrentTaxYearMinus3Years |
| Current Tax Year Minus2 Years | 9285 | CurrentTaxYearMinus2Years |
| Current Tax Year Minus1 Year | 8760 | CurrentTaxYearMinus1Year |
| Current Tax Year | 7085 | CurrentTaxYear |
| Total | 68432 | Total |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | 11210732 | TotalSupport |
| Gross Receipts From Admissions Etc | 567862 | GrossReceiptsFromAdmissionsEtc |
| Public Support Pertcentage170 | 0.45060 | PublicSupportPertcentage170 |
| Public Support Pertcent Prior Year | 0.44450 | PublicSupportPertcentPriorYear |
| Thirty Three Percnt Tests CY170 | X | ThirtyThreePercntTestsCY170 |
Schedule B IRS990ScheduleB
Contributor Info ContributorInfo
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor Number | RESTRICTED | ContributorNumber |
Contributor Name Business ContributorNameBusiness
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor Address US ContributorAddressUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Aggregate Contributions | RESTRICTED | AggregateContributions |
Schedule D IRS990ScheduleD
Current Year CurrentYear
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Of Year Balance | 5934328 | BeginningOfYearBalance |
| Contributions | 350 | Contributions |
| Investment Earnings Or Losses | 886373 | InvestmentEarningsOrLosses |
| Other Expenditures | 539855 | OtherExpenditures |
| End Of Year Balance | 6281196 | EndOfYearBalance |
Current Year Minus1 Year CurrentYearMinus1Year
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Of Year Balance | 5554292 | BeginningOfYearBalance |
| Contributions | 7295 | Contributions |
| Investment Earnings Or Losses | 899095 | InvestmentEarningsOrLosses |
| Other Expenditures | 526354 | OtherExpenditures |
| End Of Year Balance | 5934328 | EndOfYearBalance |
Current Year Minus2 Years CurrentYearMinus2Years
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Of Year Balance | 6505305 | BeginningOfYearBalance |
| Contributions | 900 | Contributions |
| Investment Earnings Or Losses | -1659001 | InvestmentEarningsOrLosses |
| Other Expenditures | -707088 | OtherExpenditures |
| End Of Year Balance | 5554292 | EndOfYearBalance |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Board Designated EOY Balance | 0.07960 | BoardDesignatedEOYBalance |
| Permanent Endowment EOY Balance | 0.76070 | PermanentEndowmentEOYBalance |
| Term Endowment EOY Balance | 0.15970 | TermEndowmentEOYBalance |
| Endowments Held By Unrelated Orgs | 0 | EndowmentsHeldByUnrelatedOrgs |
| Endowments Held By Related Orgs | 0 | EndowmentsHeldByRelatedOrgs |
Equipment Equipment
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | 136358 | OtherCostOrOtherBasis |
| Depreciation | 107479 | Depreciation |
| Book Value | 28879 | BookValue |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Of Book Value Land Buildings | 28879 | TotalOfBookValueLandBuildings |
Other Liabilities OtherLiabilities
| Field | Value | IRS element (for citing) |
|---|---|---|
| Description | DUE TO ASHP | Description |
| Amount | $54,285 | Amount |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Of Amounts | 54285 | TotalOfAmounts |
| Total Revenue | 4222024 | TotalRevenue |
| Total Expenses | 2690061 | TotalExpenses |
| Excess Or Deficit For Year | 1531963 | ExcessOrDeficitForYear |
| Total Adjustments | 0 | TotalAdjustments |
| Excess Or Deficit Per FS | 1531963 | ExcessOrDeficitPerFS |
| Tot Revenue Etc Audited Fincl Stmt | 4289014 | TotRevenueEtcAuditedFinclStmt |
| Donated Srvc And Use Of Facilities | 39323 | DonatedSrvcAndUseOfFacilities |
| Other Revenues | 27667 | OtherRevenues |
| Revenue Not Rptd F990 | 66990 | RevenueNotRptdF990 |
| Revenue Subtotal | 4222024 | RevenueSubtotal |
| Revenue Not Rptd On Fin Stmt | 0 | RevenueNotRptdOnFinStmt |
| Total Revenue Per Form990 | 4222024 | TotalRevenuePerForm990 |
| Tot Expenses Etc Audited Fincl Stmt | 2757051 | TotExpensesEtcAuditedFinclStmt |
| Donated Services Use Of Facilities | 39323 | DonatedServicesUseOfFacilities |
| Other Expenses Included | 27667 | OtherExpensesIncluded |
| Expenses Not Rptd F990 | 66990 | ExpensesNotRptdF990 |
| Expenses Subtotal | 2690061 | ExpensesSubtotal |
| Expenses Not Rptd On Fin Stmt | 0 | ExpensesNotRptdOnFinStmt |
| Total Expenses Per Form990 | 2690061 | TotalExpensesPerForm990 |
Form990 Schedule D Part XIV Form990ScheduleDPartXIV (4 entries)
| IdentifierIdentifier | Return ReferenceReturnReference | ExplanationExplanation |
|---|---|---|
| DESCRIPTION OF INTENDED USE OF ENDOWMENT FUNDS: | PART V, LINE 4: | THE FOUNDATION'S ENDOWMENT PRIMARILY CONSISTS OF CONTRIBUTIONS TO THE JOSEPH A. ODDIS ENDOWMENT CAMPAIGN, THE PURPOSE OF WHICH WAS TO RAISE FUNDS FOR PROGRAMS THAT IMPROVE PHARMACY PRACTICE AND THE SAFE AND EFFECTIVE USE OF MEDICATIONS. |
| DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48: | PART X: | DURING THE YEAR ENDED MAY 31, 2011, MANAGEMENT DID NOT IDENTIFY ANY UNCERTAIN INCOME TAX POSITIONS. AT A MINIMUM, THE TAX YEARS BEGINNING IN 2007 THROUGH 2010 ARE OPEN FOR EXAMINATION BY TAX AUTHORITIES. |
| PART XII, LINE 2D - OTHER ADJUSTMENTS: | LOSS ON DISPOSITION OF ASSETS 13,391. SPECIAL EVENTS DIRECT EXPENSES 14,276. | |
| PART XIII, LINE 2D - OTHER ADJUSTMENTS: | LOSS ON DISPOSITION OF ASSETS 13,391. SPECIAL EVENTS DIRECT EXPENSES 14,276. |
Schedule G IRS990ScheduleG
Events Information EventsInformation
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name Of Event1 | WALTER JONES GOLF CLASSIC | NameOfEvent1 |
| Gross Receipts Event1 | 34400 | GrossReceiptsEvent1 |
| Charitable Contributions Event1 | 27315 | CharitableContributionsEvent1 |
| Gross Revenue Event1 | 7085 | GrossRevenueEvent1 |
| Non Cash Prizes Event1 | 853 | NonCashPrizesEvent1 |
| Rent Facility Costs Event1 | 4192 | RentFacilityCostsEvent1 |
| Food And Beverage Event1 | 4669 | FoodAndBeverageEvent1 |
| Other Direct Expenses Event1 | 4562 | OtherDirectExpensesEvent1 |
| Gross Receipts Total | 34400 | GrossReceiptsTotal |
| Charitable Contributions Total | 27315 | CharitableContributionsTotal |
| Gross Revenue Total Events | 7085 | GrossRevenueTotalEvents |
| Non Cash Prizes Total Events | 853 | NonCashPrizesTotalEvents |
| Rent Facility Costs Total Events | 4192 | RentFacilityCostsTotalEvents |
| Food And Beverage Total Events | 4669 | FoodAndBeverageTotalEvents |
| Other Direct Expenses Total Events | 4562 | OtherDirectExpensesTotalEvents |
| Direct Expense Summary Events | 14276 | DirectExpenseSummaryEvents |
| Net Income Summary | -7191 | NetIncomeSummary |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Records Maintained | 1 | RecordsMaintained |
Recipient Table RecipientTable (27 entries)
| Address Line1AddressUS/AddressLine1 | CityAddressUS/City | StateAddressUS/State | ZIP CodeAddressUS/ZIPCode | EIN Of RecipientEINOfRecipient | IRC SectionIRCSection | Amount Of Cash GrantAmountOfCashGrant | Purpose Of GrantPurposeOfGrant |
|---|---|---|---|---|---|---|---|
| ALLINA HOSPITALS AND CLINICS | |||||||
| PO BOX 43 | MINNEAPOLIS | MN | 55440 | 363261413 | 501(C)(3) | 12910 | 2009 MEDICATION SAFETY GRANT |
| AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | |||||||
| 7272 WISCONSIN AVE | BETHESDA | MD | 20814 | 520807628 | 501(C)(6) | 24766 | CLINICAL SKILLS COMPETITION GRANT |
| AMERICAN FOUNDATION FOR PHARMACEUTICAL EDUCATION | |||||||
| 1 CHURCH ST STE 202 | ROCKVILLE | MD | 20850 | 530214882 | 501(C)(3) | 5000 | PRE-DOCTORAL FELLOWSHIP |
| ARIZONA BOARD OF REGENTS | |||||||
| PO BOX 3308 | TUCSON | AZ | 857223308 | 860779656 | 501(C)(3) | 5000 | 2010 PHARMACY RESIDENT PRACTICAL GRANT |
| BOARD OF REGENTS UNIV OF WISCONSIN | |||||||
| 1220 LINDEN DR | MADISON | WI | 53706 | 396006492 | 501(C)(3) | 6406 | FEDERAL SERVICES RESEARCH GRANT |
| BRIGHAM AND WOMEN'S HOSPITAL | |||||||
| 75 FRANCIS STREET | BOSTON | MA | 02115 | 042312909 | 501(C)(3) | 6605 | 2010 JR INVESTING RESEARCH GRANT |
| DUKE UNIVERSITY MEDICAL CENTER | |||||||
| 2301 ERWIN ROAD | DURHAM | NC | 27705 | 562070036 | 501(C)(3) | 5000 | ONCOLOGY TRAINEESHIP |
| KAISER FOUNDATION HEALTH PLAN OF COLORADO | |||||||
| 16601 E CENTRETECH PKWY | AURORA | CO | 800119045 | 840591617 | 501(C)(3) | 6520 | 2010 JR INVEST GRANT |
| KAISER FOUNDATION HEALTH PLAN OF GEORGIA INC | |||||||
| ONE KAISER PLAZA STE 15L | OAKLAND | CA | 94612 | 581592076 | 501(C)(3) | 5000 | 2010 PHARMACY RESIDENT PRACTICAL GRANT |
| KINGSBROOK JEWISH MEDICAL CENTER | |||||||
| 585 SCHENECTADY AVE | BROOKLYN | NY | 11203 | 111631759 | 501(C)(3) | 10000 | 2010 AWARD FOR EXCELLENCE |
| LANCASTER GENERAL HOSPITAL | |||||||
| PO BOX 3555 | LANCASTER | PA | 17604 | 231365353 | 501(C)(3) | 10000 | 2010 AWARD FOR EXCELLENCE |
| MASSACHUSETTS COLLEGE OF PHARMACY | |||||||
| 179 LONGWOOD AVE | BOSTON | MA | 02115 | 042104700 | 501(C)(3) | 8333 | 2009 JR INVEST GRANT |
| MAYO CLINIC | |||||||
| 200 FIRST STREET SW | ROCHESTER | MN | 55905 | 416011702 | 501(C)(3) | 16500 | 2009 EMERGENCY CARE GRANT |
| MEDICAL UNIVERSITY HOSPITAL AUTHORITY | |||||||
| 169 ASHLEY AVE STE 203 | CHARLESTON | SC | 29403 | 571098556 | 501(C)(3) | 50000 | 2010 AWARD FOR EXCELLENCE |
| SAINT LUKE'S EPISCOPAL HOSPITAL | |||||||
| 6720 BERTNER | HOUSTON | TX | 77030 | 741161938 | 501(C)(3) | 13600 | 2008 MEDICATION SAFETY |
| TENNESSEE VALLEY HEALTH CARE SYSTEMMIDDLE TENN RES INSTITUTE | |||||||
| 1310 24TH AVE S | NASHVILLE | TN | 37212 | 741161938 | 501(C)(3) | 7619 | 2010 FEDERAL SERVICES JR. INVESTIGATOR GRANT |
| THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS | |||||||
| 506 S WRIGHT STREET 209 HAB MC 339 | URBANA | IL | 61801 | 376000511 | 501(C)(3) | 5000 | 2010 PHARMACY RESIDENT PRACTICE GRANT |
| UNIVERSITY HOSPITAL | |||||||
| 234 GOODMAN ST | CINCINNATI | OH | 45219 | 311479038 | 501(C)(3) | 5000 | 2010 PHARMACY RESIDENT PRACTICE GRANT |
| UNIVERSITY OF IOWA | |||||||
| 4 JESSUP HALL | IOWAS CITY | IA | 52242 | 426004813 | 501(C)(3) | 13200 | 2009 MEDICATION SAFETY TEAM GRANT |
| UNIVERSITY OF MARYLAND BALTIMORE | |||||||
| 620 W LEXINGTON ST | BALTIMORE | MD | 21201 | 526002033 | 501(C)(3) | 8250 | 2010 PROMOTING INFLUENZA PREVENTION |
| UNIVERSITY OF ROCHESTER MEDICAL CENTER | |||||||
| 601 ELMWOOD AVE | ROCHESTER | NY | 14642 | 160743209 | 501(C)(3) | 13670 | RESIDENCY GRANT/2009 EMERGENCY CARE GRANT |
| VIRGINIA COMMONWEALTH UNIVERSITY | |||||||
| PO BOX 980568 | RICHMOND | VA | 232980568 | 546001758 | 501(C)(3) | 6800 | JR INVESTIGATOR GRANT |
| WEST VIRGINIA UNIVERSITY HOSPITAL | |||||||
| 1 MEDICAL CENTER DR | MORGANTOWN | WV | 26506 | 550643304 | 501(C)(3) | 6667 | JR. INVESTIGATOR GRANT |
| WEST VIRGINIA UNIVERSITY RESEARCH CORPORATION | |||||||
| 886 CHESTNUT RIDGE RD RM723 | MORGANTOWN | WV | 26505 | 550665758 | 501(C)(3) | 8250 | 2010 PROMOTING INFLUENZA PREVENTION |
| WISHARD FOUNDATION | |||||||
| 1001 W 10TH ST | INDIANAPOLIS | IN | 462022879 | 311132066 | 501(C)(3) | 13598 | 2008 MEDICATION SAFETY GRANT |
| ALASKA NATIVE TRIBAL HEALTH CONSORTIUM | |||||||
| 4000 AMBASSADOR DRIVE | ANCHORAGE | AK | 99508 | 920162721 | 501(C)(3) | 8250 | FEDERAL SERVICES RESEARCH GRANT |
| PALO ALTO INSTITUTE FOR RESEARCH & EDUCATION | |||||||
| PO BOX V-38 | PALO ALTO | CA | 943040038 | 770207331 | 501(C)(3) | -12000 | 2009 FEDERAL SERVICES GRANT/RESEARCH BOOT CAMP REFUNDS |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Nbr Of501 C3 And Govt Grants | 26 | TotalNbrOf501C3AndGovtGrants |
| Total Nbr Of Other Organizations | 1 | TotalNbrOfOtherOrganizations |
Form990 Schedule I Part III Form990ScheduleIPartIII (7 entries)
| Type Of GrantTypeOfGrant | Number Of RecipientsNumberOfRecipients | Amount Of Cash GrantAmountOfCashGrant |
|---|---|---|
| STERILE PRODUCTS OUTSOURCING TOOL PROGRAM | 14 | 13000 |
| LITERATURE AWARDS PROGRAM | 10 | 16500 |
| RESEARCH BOOT CAMP | 1 | 3200 |
| STUDENT LEADERSHIP AWARDS | 10 | 25000 |
| ANTITHROMBOTIC TOOL PANEL | 10 | 10000 |
| EXCELLENCE AWARDS | 12 | 7600 |
| MULTI-SITE SPECIAL HONORARIA | 11 | 4233 |
Form990 Schedule I Part IV Form990ScheduleIPartIV
| Field | Value | IRS element (for citing) |
|---|---|---|
| Identifier | PROCEDURE FOR MONITORING GRANTS IN THE U.S.: | Identifier |
| Return Reference | PART I, LINE 2: | ReturnReference |
| Explanation | SCHEDULE I, PART I, LINE 2: THE ASHP FOUNDATION HAS A DETAILED REPORTING REQUIREMENT FOR ALL GRANTS AWARDED WHICH INCLUDES REPORTING PROGRESS AT 6-MONTH INTERVALS. ANY UNUSED GRANT FUNDS MUST BE RETURNED. THE ASHP FOUNDATION HAS A GOOD TRACK RECORD OF ENSURING STUDY COMPLETION AND PUBLICATION OF STUDY RESULTS. | Explanation |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | X | CompensationCommittee |
| Form990 Of Other Organizations | X | Form990OfOtherOrganizations |
| Written Employment Contract | X | WrittenEmploymentContract |
| Compensation Survey | X | CompensationSurvey |
| Board Or Committee Approval | X | BoardOrCommitteeApproval |
| Severance Payment | 0 | SeverancePayment |
| Supplemental Nonqual Retire Plan | 0 | SupplementalNonqualRetirePlan |
| Equity Based Comp Arrangement | 0 | EquityBasedCompArrangement |
| Comp Based On Revenue Of Filing Org | 0 | CompBasedOnRevenueOfFilingOrg |
| Comp Based On Revenue Related Orgs | 0 | CompBasedOnRevenueRelatedOrgs |
| Comp Based Net Earnings Filing Org | 0 | CompBasedNetEarningsFilingOrg |
| Comp Based Net Earnings Relate Orgs | 0 | CompBasedNetEarningsRelateOrgs |
| Any Non Fixed Payments | 0 | AnyNonFixedPayments |
| Initial Contract Exception | 0 | InitialContractException |
Form990 Schedule J Part II Form990ScheduleJPartII (4 entries)
| Base Compensation Filing OrgBaseCompensationFilingOrg | Comp Based On Related OrgsCompBasedOnRelatedOrgs | Bonus Filing OrgBonusFilingOrg | Bonus Related OrgsBonusRelatedOrgs | Other Compensation Filing OrgOtherCompensationFilingOrg | Other Compensation Related OrgsOtherCompensationRelatedOrgs | Deferred Comp Filing OrgDeferredCompFilingOrg | Deferred Comp Related OrgsDeferredCompRelatedOrgs | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrg | Nontaxable Benefits Related OrgsNontaxableBenefitsRelatedOrgs | Total Compensation Filing OrgTotalCompensationFilingOrg | Total Compensation Related OrgsTotalCompensationRelatedOrgs | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrg | Comp Report Prior990 Related OrgsCompReportPrior990RelatedOrgs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HENRI R MANASSE JR PHD SCD | |||||||||||||
| 0 | 683798 | 0 | 32500 | 0 | 29856 | 0 | 61000 | 0 | 22898 | 0 | 830052 | 0 | 0 |
| STEPHEN J ALLEN MS FASHP | |||||||||||||
| 219538 | 0 | 10000 | 0 | 10676 | 0 | 24943 | 0 | 10015 | 0 | 275172 | 0 | 0 | 0 |
| DANIEL COBAUGH | |||||||||||||
| 154062 | 0 | 6647 | 0 | 465 | 0 | 17341 | 0 | 9828 | 0 | 188343 | 0 | 0 | 0 |
| RICHARD WALLING | |||||||||||||
| 139836 | 0 | 6874 | 0 | 1774 | 0 | 12973 | 0 | 1736 | 0 | 163193 | 0 | 0 | 0 |
Schedule M IRS990ScheduleM
Securities Publicly Traded SecuritiesPubliclyTraded
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | X | NonCashCheckbox |
| Number Of Contributions | 1 | NumberOfContributions |
| Noncash Contribs Rptd F990 | 58615 | NoncashContribsRptdF990 |
| Method Of Determining Revenues | CASH SALE VALUE | MethodOfDeterminingRevenues |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Any Property That Must Be Held | 0 | AnyPropertyThatMustBeHeld |
| Review Process Unusual NC Gifts | 0 | ReviewProcessUnusualNCGifts |
| Third Parties Used | 0 | ThirdPartiesUsed |
Schedule O IRS990ScheduleO
General Explanation GeneralExplanation (7 entries)
| IdentifierIdentifier | ExplanationExplanation | Return ReferenceReturnReference |
|---|---|---|
| FORM 990, PART VI, SECTION A, LINE 2 | BUSINESS RELATIONSHIP - MICHAEL S. FLAGSTAD AND LYNNAE M. MAHANEY. | |
| FORM 990, PART VI, SECTION A, LINE 7A | THREE MANDATORY MEMBERS OF THE FOUNDATION'S BOARD OF DIRECTORS ARE: THE IMMEDIATE PAST PRESIDENT, EXECUTIVE VICE PRESIDENT, AND TREASURER OF THE AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS, A RELATED 501(C)(6) MEMBERSHIP ORGANIZATION. THE AFOREMENTIONED TREASURER AND EXECUTIVE VICE PRESIDENT SHALL SERVE, RESPECTIVELY, AS THE TREASURER AND PRESIDENT OF THE THE FOUNDATION, AND THE IMMEDIATE PAST PRESIDENT SHALL SERVE AS A DIRECTOR OF THE FOUNDATION. THE BOARD OF DIRECTORS OF THE AMERICAN SOCIETY OF HEALTHSYSTEM PHARMACISTS MAY ALSO APPOINT ONE OR MORE MEMBERS OF THE PUBLIC TO SERVE AS MEMBERS OF THE FOUNDATION'S BOARD. | |
| FORM 990, PART VI, SECTION A, LINE 8B | THERE ARE NO COMMITTEES THAT HAVE THE AUTHORITY TO ACT ON BEHALF OF THE GOVERNING BODY. | |
| FORM 990, PART VI, SECTION B, LINE 11 | THE FORM 990 IS REVIEWED BY THE CHIEF OPERATIONS AND FINANCIAL OFFICERS AND BY THE BOARD (SERVING AS THE AUDIT COMMITTEE) BEFORE IT IS FILED. A COPY OF THE FORM 990 IS PROVIDED TO EACH MEMBER OF THE BOARD OF DIRECTORS. | |
| ANNUALLY AT THE MARCH MEETING | FORM 990, PART VI, SECTION B, LINE 12C | |
| CEO, EXECUTIVE DIRECTOR OR TOP MANAGEMENT: A "CEO EVALUATION SUBCOMMITTEE" IS APPOINTED BY THE BOARD AND MEETS SEVERAL TIMES ON AN ANNUAL BASIS. THIS SUBCOMMITTEE IS RESPONSIBLE FOR EVAULATING CEO PERFORMANCE ANNUALLY AND NEGOTIATING A CONTRACT THAT CUSTOMARILY SPANS A 3-YEAR PERIOD. THE TREASURER CHAIRS THE SUBCOMMITTEE DURING THE CONTRACT RENEGOTIATION YEAR AND THE BOARD CHAIR LEADS THE SUBCOMMITTEE DURING NON-CONTRACT YEAR ANNUAL REVIEWS. ALL SUBCOMITTEE ACTIONS ARE REVIEWED BY THE FULL BOARD PRIOR TO TAKING ANY ACTIONS. ONE FULL YEAR PRIOR TO THE COMPLETION OF A CONTRACT CYCLE, THE SUBCOMMITTEE COORDINATES A 360-DEGREE PERFORMANCE REVIEW, SECURING INPUT FROM THE FOUNDATION AND ASHP STAFF, FOUNDATION VOLUNTEERS, AND REPRESENTATIVES FROM THE CORPORATE COMMUNITY WHO HAVE SPONSORED PROGRAMS FOR THE FOUNDATION. ADDITIONALLY, A CEO SELF-ASSESSMENT IS COMPLETED AND REVIEWED BY THE SUBCOMMITTEE. THE 360-DEGREE PERFORMANCE REVIEW AND SELF-ASSESSMENT IS CONSIDERED BY THE BOARD AND A DECISION IS MADE AS TO WHETHER THE BOARD DESIRES TO RENEGOTIATE A NEW CONTRACT WITH THE EXISTING CEO OR SEEK A REPLACEMENT. IF A REPLACEMENT IS DESIRED, THEN A SEARCH COMMITTEE IS APPOINTED. IF CONTRACT RENEGOTIATION WITH THE CURRENT CEO IS DESIRED, THE CEO EVALUATION COMMITTEE LEADS CONTRACT RENEGOTIATIONS UNDER THE LEADERSHIP OF THE TREASURER. A CONTRACT FOR THE BOARD'S CONSIDERATION IS ESTABLISHED IN WRITING WITH ALL PROVISIONS OUTLINED, INCLUDING COMPENSATION AND BENEFITS. TO DETERMINE PROPOSED COMPENSATION THE SUBCOMMITTEE REVIEWS 1) NATIONAL SURVEY DATA FOR CHIEF PHARMACY OFFICERS SINCE THIS IS A LIKELY AND COMPETITIVE CANDIDATE POOL FOR THE CEO POSITION; 2) THE AMERICAN SOCIETY OF ASSOCIATION EXECUTIVE (ASAE) COMPENSATION DATA FOR EXECUTIVES IS REVIEWED FOCUSING ON SIMILAR/COMPETITIVE HEALTHCARE ORGANIZATIONS IN THE MID-ATLANTIC REGION; AND 3) GUIDESTAR'S DATABASE IS REFERENCED TO IDENTIFY CEO COMPENSATION IN COMPETITIVE ORGANIZATION'S 990 FILINGS. ULTIMATELY, A NEW CONTRACT IS PRESENTED TO THE BOARD FOR APPROVAL THAT OUTLINES COMPENSATION AND PERFORMANCE EXPECTATIONS. IN NON-CONTRACT RENEWAL YEARS, THE SUBCOMMITTEE COMPLETES A DRAFT ANNUAL PERFORMANCE REVIEW FOR THE BOARDS CONSIDERATION PRIOR TO CONDUCTING THE ANNUAL PERFORMANCE REVIEW ALONG WITH A SET OF CEO PERFORMANCE OBJECTIVES FOR THE UPCOMING YEAR AND A CEO SELF-ASSESSMENT SUMMARY. IN ALL CASES CEO PERFORMANCE IS MEASURED AGAINST BOARD-APPROVED ANNUAL PERFORMANCE OBJECTIVES. OTHER OFFICERS OR KEY EMPLOYEES: THE CEO DETERMINES COMPENSATION FOR KEY EMPLOYEES RELYING HEAVILY UPON THE GUIDANCE OF THE HUMAN RESOURCES DEPARTMENT OF ASHP. ASAE SURVEY DATA IS REVIEWED WHEN COMPARABLE POSITIONS EXIST FOR THE KEY EMPLOYEE POSITION (E.G. DIRECTOR OF COMMUNICATIONS). THE HUMAN RESOURCES DEPARTMENT UTILIZES ADDITIONAL SALARY SURVEY DATABASES TO COMPARE SALARIES. FOR POSITIONS WHERE A PHARAMCIST IS A JOB REQUIREMENT, PHARMACIST POSITIONS IN HOSPITALS AND HEALTH-SYSTEMS THAT WOULD BE LIKELY CANDIDATE POOLS ARE QUERIED IN THE SALARY SURVEY DATABASES. ADDITIONALLY, THE HR DEPARTMENT CAN PROVIDE COMPARATIVE DATA FOR PHARMACIST POSITIONS AT ASHP. | FORM 990, PART VI, SECTION B, LINE 15A | |
| THE FOUNDATION'S FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST PER ITS ANNUAL REPORT. THE FOUNDATION ALSO MAKES ITS GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY AVAILABLE UPON REQUEST. | FORM 990, PART VI, SECTION C, LINE 19 |
Schedule R IRS990ScheduleR
Form990 Schedule R Part II Form990ScheduleRPartII (2 entries)
| Address Line1AddressUS/AddressLine1 | CityAddressUS/City | StateAddressUS/State | ZIP CodeAddressUS/ZIPCode | EINEIN | Primary ActivitiesPrimaryActivities | Legal Domicile StateLegalDomicileState | Exempt Code SectionExemptCodeSection | Direct Controlling Entity NADirectControllingEntityNA | Controlled OrgControlledOrg | Business Name Line1DirectControllingEntityName/BusinessNameLine1 |
|---|---|---|---|---|---|---|---|---|---|---|
| AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS (ASHP) | ||||||||||
| 7272 WISCONSIN AVENUE | BETHESDA | MD | 20814 | 520807628 | TO ADVANCE PUBLIC HEALTH BY SUPPORTING THE PHARMACY PROFESSION | MD | 501(C)(6) | N/A | 0 | |
| 7272 WISCONSIN BUILDING CORPORATION | ||||||||||
| 7272 WISCONSIN AVENUE | BETHESDA | MD | 20814 | 521760057 | TITLE HOLDING COMPANY | MD | 501(C)(2) | 0 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Ann Rents Royalties | 0 | ReceiptOfIntAnnRentsRoyalties |
| Gift Grant Or Cap Contr To Other Org | 1 | GiftGrantOrCapContrToOtherOrg |
| Gift Grant Or Cap Contr Fr Other Org | 1 | GiftGrantOrCapContrFrOtherOrg |
| Loans Or Guarantees To Other Org | 0 | LoansOrGuaranteesToOtherOrg |
| Loans Or Guarantees From Other Org | 0 | LoansOrGuaranteesFromOtherOrg |
| Sale Of Assets To Other Org | 0 | SaleOfAssetsToOtherOrg |
| Purchase Of Assets From Other Org | 0 | PurchaseOfAssetsFromOtherOrg |
| Exchange Of Assets | 0 | ExchangeOfAssets |
| Rental Of Facilities To Other Orgs | 0 | RentalOfFacilitiesToOtherOrgs |
| Rental Of Facilities Fr Other Orgs | 0 | RentalOfFacilitiesFrOtherOrgs |
| Perform Of Services For Other Orgs | 0 | PerformOfServicesForOtherOrgs |
| Perform Of Services By Other Orgs | 1 | PerformOfServicesByOtherOrgs |
| Sharing Of Facilities | 1 | SharingOfFacilities |
| Sharing Of Paid Employees | 1 | SharingOfPaidEmployees |
| Reimbursement Paid To Other Org | 1 | ReimbursementPaidToOtherOrg |
| Reimbursement Paid By Other Org | 0 | ReimbursementPaidByOtherOrg |
| Other Transfer To Other Org | 0 | OtherTransferToOtherOrg |
| Other Transfer From Other Org | 1 | OtherTransferFromOtherOrg |
Transactions Related Orgs Table TransactionsRelatedOrgsTable (7 entries)
| Transaction TypeTransactionType | Amount InvolvedAmountInvolved | Method Of Amt DeterminationMethodOfAmtDetermination |
|---|---|---|
| AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | ||
| O | 1523144 | RECORDED EXPENSES |
| AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | ||
| M | 679084 | RECORDED EXPENSES |
| AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | ||
| R | 844059 | CASH |
| AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | ||
| C | 328400 | CASH |
| AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | ||
| N | 39323 | FAIR VALUE |
| AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | ||
| B | 24766 | CASH |
| AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | ||
| L | 81500 | CASH |
Comments